Thomas E. Morrison

7.6k total citations · 1 hit paper
116 papers, 5.5k citations indexed

About

Thomas E. Morrison is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Thomas E. Morrison has authored 116 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Infectious Diseases, 71 papers in Public Health, Environmental and Occupational Health and 28 papers in Immunology. Recurrent topics in Thomas E. Morrison's work include Mosquito-borne diseases and control (68 papers), Viral Infections and Vectors (53 papers) and Viral Infections and Outbreaks Research (29 papers). Thomas E. Morrison is often cited by papers focused on Mosquito-borne diseases and control (68 papers), Viral Infections and Vectors (53 papers) and Viral Infections and Outbreaks Research (29 papers). Thomas E. Morrison collaborates with scholars based in United States, France and Australia. Thomas E. Morrison's co-authors include Mark T. Heise, Michael Diamond, Alan C. Whitmore, Stephanie A. Montgomery, Kristina S. Burrack, Ralph S. Baric, Shannon C. Kenney, Lauren Oko, Timothy P. Sheahan and Mary K. McCarthy and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Thomas E. Morrison

112 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

2018 479 citations Thomas E. Morrison et al. mBio profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas E. Morrison	3.1k	2.3k	1.6k	917	873	116	5.5k
Jonathan J. Miner	2.5k 0.8×	2.6k 1.1×	1.7k 1.0×	1.2k 1.3×	1.0k 1.2×	53	5.4k
Jean K. Lim	3.8k 1.2×	1.6k 0.7×	1.9k 1.2×	1.2k 1.3×	1.3k 1.5×	68	6.5k
Peter Kern	1.5k 0.5×	863 0.4×	1.1k 0.7×	493 0.5×	759 0.9×	152	7.2k
Mehul S. Suthar	4.1k 1.3×	2.6k 1.1×	2.1k 1.3×	1.5k 1.6×	1.1k 1.3×	108	6.8k
Helen M. Lazear	2.8k 0.9×	2.3k 1.0×	1.8k 1.1×	861 0.9×	1.2k 1.4×	53	5.2k
Alan C. Whitmore	2.3k 0.8×	843 0.4×	1.2k 0.7×	817 0.9×	536 0.6×	66	4.0k
Michael S. Diamond	2.4k 0.8×	2.6k 1.1×	1.2k 0.7×	637 0.7×	609 0.7×	47	4.3k
Penghua Wang	2.4k 0.8×	2.5k 1.1×	1.5k 0.9×	1.3k 1.4×	565 0.6×	103	5.7k
Sujan Shresta	4.7k 1.5×	5.0k 2.2×	2.5k 1.5×	1.7k 1.9×	1.5k 1.8×	104	8.8k
Roger Le Grand	2.8k 0.9×	1.7k 0.8×	2.8k 1.7×	1.4k 1.5×	1.6k 1.8×	283	7.7k

Countries citing papers authored by Thomas E. Morrison

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Morrison more than expected).

Fields of papers citing papers by Thomas E. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Morrison. The network helps show where Thomas E. Morrison may publish in the future.

Co-authorship network of co-authors of Thomas E. Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Morrison. A scholar is included among the top collaborators of Thomas E. Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Morrison. Thomas E. Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stumpf, Megan M., Tonya M. Brunetti, Bennett Davenport, Mary K. McCarthy, & Thomas E. Morrison. (2025). Deep mutationally scanned CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies. Journal of Virology. 99(4). e0008125–e0008125. 2 indexed citations

Yin, Peiqi, Nicholas May, Sainan Wang, et al.. (2025). Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4′-Fluorouridine. PLoS Pathogens. 21(1). e1012859–e1012859. 3 indexed citations

Sheridan, Ryan M., Glennys V. Reynoso, Bennett Davenport, et al.. (2024). Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO. JCI Insight. 9(4). 1 indexed citations

Ander, Stephanie E., Bennett Davenport, Angela M. Bosco‐Lauth, et al.. (2024). Phagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner. PNAS Nexus. 3(4). pgae119–pgae119. 4 indexed citations

Lucas, Erin D., Ira Fleming, Jenna J. Guthmiller, et al.. (2024). Immunization-induced antigen archiving enhances local memory CD8+ T cell responses following an unrelated viral infection. npj Vaccines. 9(1). 66–66. 2 indexed citations

Davenport, Bennett, et al.. (2024). Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine Candidate. Vaccines. 12(11). 1201–1201. 1 indexed citations

Martin, Caroline, Peiqi Yin, Thomas E. Morrison, et al.. (2024). The alphavirus determinants of intercellular long extension formation. mBio. 16(2). e0198624–e0198624. 1 indexed citations

Wang, Leran, Brian C. Ware, Ray A. Ohara, et al.. (2024). Type I interferon signaling in dendritic cells limits direct antigen presentation and CD8 ⁺ T cell responses against an arthritogenic alphavirus. mBio. 15(12). e0293024–e0293024. 3 indexed citations

Broome, Kieran, et al.. (2023). Investigation of the Consumer Perspective on Leisure in Mental Health Inpatient Units. OTJR Occupational Therapy Journal of Research. 44(1). 67–77. 1 indexed citations

10.

Yin, Peiqi, Bennett Davenport, Arthur S. Kim, et al.. (2023). Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo. Nature Microbiology. 8(9). 1653–1667. 20 indexed citations

11.

Davenport, Bennett, Stuart Weston, Robert M. Johnson, et al.. (2022). Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease. npj Vaccines. 7(1). 57–57. 16 indexed citations

12.

Knight, Vijaya, Patricia Merkel, Molly M. Lamb, et al.. (2022). COVID-19 Serology Control Panel Using the Dried-Tube Specimen Method. American Journal of Tropical Medicine and Hygiene. 106(2). 562–565.

13.

Sheridan, Ryan M., Bennett Davenport, Erin D. Lucas, et al.. (2021). MARCO ⁺ lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination. The EMBO Journal. 40(22). e108966–e108966. 21 indexed citations

14.

Annen, Kyle, et al.. (2021). Presence and short‐term persistence of SARS‐CoV ‐2 neutralizing antibodies in COVID ‐19 convalescent plasma donors. Transfusion. 61(4). 1148–1159. 9 indexed citations

15.

Wang, Guankui, Hanmant Gaikwad, Mary K. McCarthy, et al.. (2021). Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro. SHILAP Revista de lepidopterología. 4(1). 724–737. 18 indexed citations

16.

Fox, Julie M., Nurgun Kose, Arthur S. Kim, et al.. (2020). Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease. PLoS Pathogens. 16(5). e1008517–e1008517. 20 indexed citations

17.

Decker, Carolyn J., Laura L. Hoon‐Hanks, James H. Morrison, et al.. (2019). dsRNA-Seq: Identification of Viral Infection by Purifying and Sequencing dsRNA. Viruses. 11(10). 943–943. 18 indexed citations

18.

Lucas, Erin D., Matthew A. Burchill, Mary K. McCarthy, et al.. (2018). Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response. The Journal of Immunology. 201(6). 1735–1747. 48 indexed citations

19.

Hawman, David W., Julie M. Fox, Nicholas May, et al.. (2017). Mutations in the E2 Glycoprotein and the 3′ Untranslated Region Enhance Chikungunya Virus Virulence in Mice. Journal of Virology. 91(20). 32 indexed citations

20.

Monin, Leticia, Kristin Griffiths, Wing Y. Lam, et al.. (2015). Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis. Journal of Clinical Investigation. 125(12). 4699–4713. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact